Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MDLive vs MedLeanRx

MDLive
Graded #357

Lower grade

vs+15.100000000000009
MedLeanRx
Graded #69

Higher grade

The verdict

MedLeanRx takes it — 73.9/100 to 58.8/100.

MedLeanRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedLeanRx +29
45
74
Dose & formulationMedLeanRx +40
53
93
Clinical oversightMDLive +8
85
77
Labs & monitoringMDLive +2
54
52
FulfillmentMedLeanRx +15
62
77
Contract termsEven
55
55
MDLive · left barMedLeanRx · right bar

The numbers

MetricMDLiveMedLeanRx
WeighScore58.8/10073.9/100
GradeCC
Scorecard rank#357#69
SemaglutideNot disclosed$149/mo (starting dose, promotional rate, compounded)
TirzepatideNot disclosed$269/mo (starting dose, compounded)
CoverageCoverage not published1 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
MDLive

Graded #357 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s including Wegovy and Zepbound
  • Covered through insurance and employer benefits for 50M-plus people
  • Board-certified physicians averaging about 15 years of experience
  • Part of Evernorth/Cigna, a large established healthcare organization
  • Offers full primary care, not just a single weight-loss funnel

Where it loses points

  • GLP-1s only at clinician discretion in a Primary Care routine visit
  • Anti-obesity meds not available in FL, LA, MS or NJ
  • Distributed mainly via insurers and employers; cost varies by plan
  • No transparent published monthly cash price for GLP-1 care
MedLeanRx

Graded #69 · C

Strengths

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

Where it loses points

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard